1. Home
  2. ACU vs CDXS Comparison

ACU vs CDXS Comparison

Compare ACU & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

N/A

Current Price

$41.44

Market Cap

154.0M

ML Signal

N/A

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.67

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
CDXS
Founded
1867
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
141.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ACU
CDXS
Price
$41.44
$1.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.1K
1.1M
Earning Date
02-27-2026
02-26-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
$52,932,000.00
Revenue This Year
$2.19
$15.64
Revenue Next Year
$4.55
$5.23
P/E Ratio
$17.26
N/A
Revenue Growth
2.35
N/A
52 Week Low
$34.35
$1.52
52 Week High
$45.25
$5.43

Technical Indicators

Market Signals
Indicator
ACU
CDXS
Relative Strength Index (RSI) 64.21 45.13
Support Level $38.83 $1.58
Resistance Level $43.13 $1.74
Average True Range (ATR) 1.10 0.07
MACD 0.03 0.01
Stochastic Oscillator 74.89 41.18

Price Performance

Historical Comparison
ACU
CDXS

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: